Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bismuth Add-on to Vonoprazan-Amoxicillin Dual Therapy for H. pylori Eradication
NCT07576959Phase 3Recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Apr 2026
- Primary completion
- Dec 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bismuth subsalicylate in Helicobacter pylori infection, sponsored by National Taiwan University Hospital. Started Apr 2026; status: recruiting.
02
Drugs
bismuth subsalicylate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07576959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07576959.